logo
Ipsen delivers strong results in the first half of 2025 and upgrades its full-year guidance

Ipsen delivers strong results in the first half of 2025 and upgrades its full-year guidance

Toronto Star2 days ago
H1 total sales growth of 11.4% at CER1, or 9.7% as reported, driven by the three therapeutic areas: 95.7% in Rare Disease, 9.7% in Neuroscience, and 6.4% in Oncology
H1 core operating income of €656m, growing by 21.9% as reported, with a core operating margin of 36.0% of total sales, increasing by 3.6 points
Upgraded FY 2025 financial guidance2: total-sales growth greater than 7.0% at CER (prior guidance: greater than 5.0% at CER); core operating margin greater than 32.0% of total sales (prior guidance: greater than 30%)
Pipeline progression including regulatory filing of tovorafenib in Europe, and initiation of a Phase II trial of LANT3 (IPN10200) in cervical dystonia
European Commission approval on 23 July 2025 of Cabometyx® in advanced neuroendocrine tumors (NETs), the sixth indication
Key upcoming milestones with the pivotal FALKON trial results for fidrisertib in FOP4 and the Proof-of-Concept data readout for the LANT in aesthetics
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

EU chief's texts to a pharma boss during pandemic were likely erased, the NYT reports
EU chief's texts to a pharma boss during pandemic were likely erased, the NYT reports

Toronto Star

time11 hours ago

  • Toronto Star

EU chief's texts to a pharma boss during pandemic were likely erased, the NYT reports

BRUSSELS (AP) — Text messages exchanged between European Commission President Ursula von der Leyen and a pharmaceutical boss during the COVID-19 pandemic were seen by her top adviser and have likely been destroyed, the New York Times reported Friday. Von der Leyen and Pfizer CEO Albert Bourla exchanged the messages as COVID-19 ravaged European communities from Portugal to Finland and the EU scrambled to buy millions of hard to find vaccines. She was under intense scrutiny to deliver.

OTC Markets Group Welcomes Talga Group Ltd. to OTCQX
OTC Markets Group Welcomes Talga Group Ltd. to OTCQX

Toronto Star

time13 hours ago

  • Toronto Star

OTC Markets Group Welcomes Talga Group Ltd. to OTCQX

NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Talga Group Ltd. (ASX: TLG; OTCQX: TLGRF), a leader in the development of sustainable battery materials, has qualified to trade on the OTCQX® Best Market. Talga Group Ltd. upgraded to OTCQX from the Pink® market. Talga Group Ltd. begins trading today on OTCQX under the symbol 'TLGRF.' U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on

OTC Markets Group Welcomes Apex Critical Metals Corp. to OTCQX
OTC Markets Group Welcomes Apex Critical Metals Corp. to OTCQX

Toronto Star

time13 hours ago

  • Toronto Star

OTC Markets Group Welcomes Apex Critical Metals Corp. to OTCQX

NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Apex Critical Metals Corp. (CSE: APXC; OTCQX: APXCF), a Canadian exploration company, has qualified to trade on the OTCQX® Best Market. Apex Critical Metals Corp. upgraded to OTCQX from the OTCQB® Venture Market. Apex Critical Metals Corp. begins trading today on OTCQX under the symbol 'APXCF.' U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store